Code | 1737E | ||||
MA number | EU/1/21/1579/003 | ||||
Product Form: | plc ifc 10x100 mg (liek.inj.skl.) | ||||
MA Status: | E - Valid centralised marketing authorisation | ||||
Type of procedure: | EU | ||||
MAH, country: | Sanofi B.V., Netherland | ||||
ATC: |
|
||||
Shelf life: | 48 | ||||
Container: | glass vial | ||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 24.06.2022 |
Validity: | 24.06.2027 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 09.11.2022 |